JTAI

Jet.AI Inc.

1.58 USD

Last updated Dec 7, 19:23 UTC

Yesterday HIGH

$1.64

Yesterday LOW

$1.47

52w HIGH

$17.5

52w LOW

$1.02

EPS

-0.61

PE

-2.59

Next Earnings

Feb 15, 2024

Overview News Government Trades

Jet.AI Inc. stock is up 35.04% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November.

Benzinga Insights

Wed Sep 6, 2023

12 Industrials Stocks Moving In Wednesday's After-Market Session
Lisa Levin

Mon Aug 21, 2023

Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares jumped 120% to $0.33.
Lisa Levin

Mon Aug 21, 2023

Why Palo Alto Networks Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares gained 53.3% to $0.23 in pre-market trading.
Happy Mohamed

Fri Aug 18, 2023

Jet.AI Shares Halted On Circuit Breaker To The Upside, Stock Now Up 77%
Happy Mohamed

Fri Aug 18, 2023

Jet.AI Shares Resume Trade
Happy Mohamed

Fri Aug 18, 2023

Jet.AI Shares Halted On Circuit Breaker To The Upside, Stock Now Up 18.8%
Happy Mohamed

Fri Aug 18, 2023

Jet.AI AI-Powered Charter Booking Platform Available Today In iOS App Store, Expected To Release On The Android Store In The Coming Weeks; Next Iteration Of The App, Due In September, Is Expected To Integrate With Stripe For Payments

Jet.AI Inc. (the "Company") (NASDAQ:JTAI), an innovative private aviation and artificial intelligence ("AI") company, today announced its AI-powered charter booking
Happy Mohamed

Tue Aug 15, 2023

Jet.AI Shares Halted On Circuit Breaker, Stock Now Down -8%
Lisa Levin

Tue Aug 15, 2023

Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket

Gainers Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma.
Happy Mohamed

Mon Aug 14, 2023

Jet.AI Shares Resumed Trade

HOOD $11.43 USD

LULU $463.10 USD

SMPL $40.38 USD

AMD $127.83 USD

GOOG $138.81 USD

LKNCY $0.00 USD

CVX $142.37 USD

DOCU $47.13 USD